Rare diseases
Investigational molecules
Locations
Birkerfeld 12, Lochham, 83627, Germany
Apurano Pharmaceuticals GmbH focuses on clinical research in persistent pain conditions, with particular attention to chronic back pain and pain linked to peripheral neuropathy and central neuropathy.
The sponsor also investigates pain associated with diabetic polyneuropathy, reflecting a strong therapeutic interest in difficult-to-treat nerve-related pain syndromes.
Apurano Pharmaceuticals GmbH runs clinical trials in conditions such as Pain, Neuropathy peripheral, Borderline personality disorder, Back pain, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
A study to evaluate the effectiveness and safety of AP707 in patients with borderline personality disorder.
GermanyStudy on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain
AustriaStudy on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain
AustriaStudy on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy
AustriaStudy on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
